Aptamer AS1411-functionalized gold nanoparticle-melittin complex for targeting MCF-7 breast cancer cell line.

MLA

Bayat, Payam, et al. “Aptamer AS1411-Functionalized Gold Nanoparticle-Melittin Complex for Targeting MCF-7 Breast Cancer Cell Line.” Nanomedicine Journal, vol. 9, no. 2, Apr. 2022, pp. 164–69. EBSCOhost, https://doi.org/10.22038/NMJ.2022.62476.1649.

APA

Bayat, P., Abnous, K., Balarastaghi, S., Taghdisi, S. M., Saeedi, M., Yazdian-Robati, R., & Mahmoudi, M. (2022). Aptamer AS1411-functionalized gold nanoparticle-melittin complex for targeting MCF-7 breast cancer cell line. Nanomedicine Journal, 9(2), 164–169. https://doi.org/10.22038/NMJ.2022.62476.1649

Chicago

Bayat, Payam, Khalil Abnous, Soudabeh Balarastaghi, Seyed Mohammad Taghdisi, Majid Saeedi, Rezvan Yazdian-Robati, and Mahmoud Mahmoudi. 2022. “Aptamer AS1411-Functionalized Gold Nanoparticle-Melittin Complex for Targeting MCF-7 Breast Cancer Cell Line.” Nanomedicine Journal 9 (2): 164–69. doi:10.22038/NMJ.2022.62476.1649.